ASAHI KAISEI CRP UNSP/ADR (AHKSY) analyst actions
Rating and price-target actions on AHKSY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AHKSY overview →
1 measured AHKSY analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases | Press release | +0.00% | -1.80% |
Keep exploring
More AHKSY: earnings → · SEC filings → · AHKSY overview →
Other Basic Materials names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Lithium Americas Corp. Common Shares (LAC) | 141 | -0.51% | 38% |
| ALUMINA LTD S/ADR (AWCMY) | 140 | 0.00% | 41% |
| Arcadia Biosciences, Inc. (RKDA) | 139 | -1.05% | 34% |
| Dynacor Gold Mines Inc (DNG_TSE) | 138 | 0.00% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.